Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis

Iwashima, Yoshio; Fukuda, Tsuyoshi; Yoshihara, Fumiki; Kusunoki, Hiroshi; Kishida, Masatsugu; Hayashi, Shinichiro; Nakamura, Satoko; Kamide, Kei; Horio, Takeshi; Kawano, Yuhei

doi:10.1097/hjh.0000000000000928

Cited by 22 publications

(22 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…At 5.1-year mean follow-up of these patients, 56 patients (32%) developed restenosis (14). In the patients with atherosclerotic RAS (70% of the group) in this study, no significant reduction in systolic blood pressure was found (14).…”

mentioning

confidence: 48%

“…At 1-year mean follow-up of 175 patients with hypertension due to RAS treated with percutaneous transluminal renal angioplasty (PTRA), 35 patients (20%) also developed restenosis (14). At 5.1-year mean follow-up of these patients, 56 patients (32%) developed restenosis (14). In the patients with atherosclerotic RAS (70% of the group) in this study, no significant reduction in systolic blood pressure was found (14).…”

mentioning

confidence: 55%

mentioning

confidence: 99%

See 2 more Smart Citations

Atherosclerotic renal artery stenosis

Aronow

2017

Ann. Transl. Med.

View full text Add to dashboard Cite

mentioning

confidence: 48%

mentioning

confidence: 55%

See 1 more Smart Citation

Atherosclerotic renal artery stenosis

Aronow

2017

Ann. Transl. Med.

View full text Add to dashboard Cite

“…In atherosclerotic renal stenosis, a history of cardiovascular disease (hazard ratio (HR) 2.84) and a 90% or greater stenosis (HR 3.95) are independent predictors of restenosis. 33 Fibromuscular dysplasia is also an independent factor of restenosis after endovascular angioplasty (HR 2.65). In these patients, primary and assisted primary patency is 95%, 71% and 50%, and 100%, 100% and 100% at 1, 5 and 9 years, respectively.…”

Section: Renal Artery Disease Mid and Long-term Outcomementioning

confidence: 99%

Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery

Venermo

Sprynger

Desormais

et al. 2019

Eur J Prev Cardiolog

View full text Add to dashboard Cite

Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular disease down to lower extremity artery disease, from subclinical to disabling symptoms and events. According to clinical presentation, the patient's general condition, anatomical location and extension of lesions, revascularisation may be needed in addition to best medical treatment. The 2017 European Society of Cardiology guidelines in collaboration with the European Society for Vascular Surgery have addressed the indications for revascularisation. While most cases are amenable to either endovascular or surgical revascularisation, maintaining long-term patency is often challenging. Early and late procedural complications, but also local and remote recurrences frequently lead to revascularisation failure. The rationale for surveillance is to propose the accurate implementation of preventive strategies to avoid other cardiovascular events and disease progression and avoid recurrence of symptoms and the need for redo revascularisation. Combined with vascular history and physical examination, duplex ultrasound scanning is the pivotal imaging technique for identifying revascularisation failures. Other non-invasive examinations (ankle and toe brachial index, computed tomography scan, magnetic resonance imaging) at regular intervals can optimise surveillance in specific settings. Currently, optimal revascularisation surveillance programmes are not well defined and systematic reviews addressing long-term results after revascularisation are lacking. We have systematically reviewed the literature addressing follow-up after revascularisation and we propose this consensus document as a complement to the recent guidelines for optimal surveillance of revascularised patients beyond the perioperative period.

show abstract

“…Furthermore, the long-term result of PTA is limited by the unwelcome occurrence of recurrent stenosis (RS) that may additionally impact the final effect of PTA. The RS rate following RAS procedures is estimated at 6-40% [5][6][7][8]11]. However, the determinants of RS are poorly established.…”

Section: Introductionmentioning

confidence: 99%

Long-term outcomes and determinants of stenosis recurrence after renal artery angioplasty in hypertensive patients with renovascular disease

Rosławiecka¹,

Kabłak‐Ziembicka²,

Badacz³

et al. 2020

pwki

View full text Add to dashboard Cite

Introduction: Restenosis (RS) following percutaneous angioplasty (PTA) of renal artery stenosis (RAS) might have an unfavourable impact on renal function and blood pressure (BP) outcomes. Aim: To evaluate the prevalence and predictors of RS in patients treated with PTA for RAS, and the relationship between BP and renal function (RF) changes with RS. Material and methods: We analysed freedom from RS in 210 patients (age 64.6 ±12.8 years; range: 20-85), who underwent 248 successful stent-assisted PTAs in RAS. The change in levels of serum creatinine (SCC), estimated glomerular filtration rate (eGFR), systolic/diastolic BPs (SBP/DBP) were analysed prior to PTA, at 6-, 12-month, and final follow-up visits, and whenever RS was diagnosed. Results: RS was identified in 30 (14.3%) patients, and there were 36 (14.5%) lesions. The Kaplan-Meier RS-free survival curves in fibromuscular dysplasia, atherosclerosis, and vasculitis at 1 and 7 years were: 100% and 100%; 95.6 and 83.9%; and 71.4 and 39.7%, respectively. Patients with RS, as compared to RS-free patients, presented with less pronounced changes in respect with:

show abstract

Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis

Abstract: The frequency of restenosis after renal PTA is significant, and the presence of restenosis diminishes the benefit of its treatment, especially for FMD.

Cited by 22 publications

References 31 publications

Atherosclerotic renal artery stenosis

Atherosclerotic renal artery stenosis

Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery

Long-term outcomes and determinants of stenosis recurrence after renal artery angioplasty in hypertensive patients with renovascular disease

Contact Info

Product

Resources

About